ICD-10-CM Billable Code

C81.3A

Lymphocyte depleted Hodgkin lymphoma, in remission

Clinical Classification Guidelines

Medical Intelligence & Overview

Lymphocyte depleted Hodgkin lymphoma is a rare subtype of Hodgkin lymphoma, characterized by a unique cellular makeup that can sometimes make it more challenging to treat. When this type of lymphoma reaches a state known as remission, it means that the signs and symptoms have significantly decreased or disappeared, usually after treatment. This article provides an overview of this condition, including its causes, symptoms, diagnosis, and treatment options, all explained in patient-friendly language.

Causes & Symptoms

Clinical Causes: T h e e x a c t c a u s e o f l y m p h o c y t e d e p l e t e d H o d g k i n l y m p h o m a r e m a i n s u n k n o w n , b u t s e v e r a l f a c t o r s m a y i n f l u e n c e i t s d e v e l o p m e n t : - G e n e t i c p r e d i s p o s i t i o n s - C e r t a i n i n f e c t i o n s , s u c h a s E p s t e i n - B a r r v i r u s - I m m u n e s y s t e m d e f i c i e n c i e s - P r e v i o u s e x p o s u r e t o r a d i a t i o n o r c e r t a i n c h e m i c a l s W h i l e t h e s e f a c t o r s c a n c o n t r i b u t e t o t h e r i s k , i t ’ s i m p o r t a n t t o u n d e r s t a n d t h a t t h e d e v e l o p m e n t o f t h i s l y m p h o m a i s c o m p l e x a n d m u l t i f a c t o r i a l .

Key Symptoms: S y m p t o m s o f l y m p h o c y t e d e p l e t e d H o d g k i n l y m p h o m a c a n v a r y a n d m a y i n c l u d e : - P a i n l e s s s w e l l i n g o f l y m p h n o d e s , e s p e c i a l l y i n t h e n e c k , a r m p i t s , o r g r o i n - F e v e r a n d n i g h t s w e a t s - U n e x p l a i n e d w e i g h t l o s s - F a t i g u e o r f e e l i n g v e r y t i r e d - I t c h i n g - C o u g h o r c h e s t d i s c o m f o r t i f l y m p h n o d e s i n t h e c h e s t a r e a f f e c t e d - P a i n o r s w e l l i n g i n o t h e r a r e a s d u e t o e n l a r g e d l y m p h n o d e s B e c a u s e t h e s e s y m p t o m s a r e c o m m o n t o m a n y i l l n e s s e s , p r o p e r m e d i c a l e v a l u a t i o n i s e s s e n t i a l f o r a n a c c u r a t e d i a g n o s i s .

Diagnostic & Treatment

Diagnosis Path: Diagnosing lymphocyte depleted Hodgkin lymphoma involves several steps: - Physical examination focusing on lymph nodes and other affected areas - Imaging tests such as CT scans or PET scans to locate enlarged lymph nodes or other signs of disease - A biopsy, where a small tissue sample from an enlarged lymph node is examined under a microscope to confirm the presence of lymphoma and determine its subtype - Laboratory tests, including blood counts and other blood work, to assess overall health and the extent of the disease These diagnostic tools help healthcare providers determine the exact nature of the lymphoma and plan appropriate treatment.

Treatment Protocols: Treatment options depend on the stage of the disease and the patient’s overall health: - Chemotherapy, which uses cancer-fighting drugs to kill malignant cells - Radiation therapy, especially if the disease is localized - Stem cell transplantation may be considered in certain cases for more aggressive or recurrent disease - Supportive care, including medications to manage symptoms and side effects It’s important for treatment to be tailored to each individual by a specialized team of healthcare providers. Following treatment, patients often enter remission, a period during which symptoms are reduced or absent. In case of relapse or progression, further treatment options may be considered, including experimental therapies or clinical trials.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C81.3A a billable ICD-10 code?
Yes, C81.3A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C81.3A?
Clinical documentation must specify the nature of Lymphocyte depleted Hodgkin lymphoma, in remission and any associated comorbidities for accurate reporting.

Cite this Clinical Reference